InsiderClue
Insiders · Profile

Wilkins H Jeffrey

Chief Medical Officer at Avalo Therapeutics. Filing since 10 Jun 2021. CIK 0001779160

Company
Date
Role
Action
Shares
Amount
Of holding
AVTX Avalo Therapeutics, Inc.
10 Dec 2021
Chief Medical Officer
Bought
6,371
$10.00K
23.6%
AVTX Avalo Therapeutics, Inc.
10 Jun 2021
Chief Medical Officer
Bought
912
$2.08K
3.5%
2 decisions on file.